Neurotoxic in vivo models of Parkinson's disease recent advances.
about
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseA Potential Alternative against Neurodegenerative Diseases: PhytodrugsGene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian modelsAdvances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's diseaseDietary factors in the etiology of Parkinson's disease.Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culturePesticides, microglial NOX2, and Parkinson's diseaseIdentification of bilateral changes in TID1 expression in the 6-OHDA rat model of Parkinson's diseasePartial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage.Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic miceMemory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitroBaicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism.Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's diseaseCognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons.Astrocytes in Parkinson's disease and DJ-1Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila.Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster.Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's diseaseBioenergetic origins of complexity and disease.Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease modelsThe role of environmental exposures in neurodegeneration and neurodegenerative diseases.A guide to neurotoxic animal models of Parkinson's diseaseNeuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.Molecular chaperones in Parkinson's disease--present and futureα-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficitsA survey of the protective effects of some commercially available antioxidant supplements in genetically and chemically induced models of oxidative stress in Drosophila melanogaster.Mitochondrial dysfunction and oxidative stress promote apoptotic cell death in the striatum via cytochrome c/caspase-3 signaling cascade following chronic rotenone intoxication in ratsThiol-redox signaling, dopaminergic cell death, and Parkinson's diseaseLack of miRNA Misregulation at Early Pathological Stages in Drosophila Neurodegenerative Disease Models.Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit.Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?LRRK2 mutations and neurotoxicant susceptibilityImpairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicityRestoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: distinct roles of superoxide anion and superoxide dismutases.Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.
P2860
Q24609725-A52F1D74-1C44-4AD8-B93B-443905895032Q26765784-5E716A2E-EC77-4DF3-BD2A-6CFC6DFF4250Q26863375-FEA8D555-D072-4261-A0CF-55312563A2E6Q27023467-E3F2AAEA-8DCC-4FE4-9FFF-982443B19566Q28085390-5D39DB20-F62B-4772-9EF2-6820B1FA9ECAQ28286470-008C9273-3D22-414B-907F-EEABFA93F325Q28397585-AE711895-210D-44A7-A6CD-709463611370Q28477415-2929CF52-5BD8-49BB-A905-1EACD2ACC07FQ28587077-FAFDAACE-DF7C-47AD-85D7-6DF008842356Q29620597-57CF25A5-41C0-455C-AA5C-6279CB1D994BQ33606408-C14A5F6D-1EC7-41D7-BA73-77B75E6D5F7DQ34048236-EA6FCDB0-3D62-419B-9BCE-3C3932C4618DQ34134659-D53130EA-08F7-41A9-A19B-00CE321E7E27Q34260081-424E320F-C803-484A-AD65-958D01BD2237Q34307633-B0A33E63-6DED-4A8A-B2CE-F87727288F82Q34503671-1E9871F9-3292-4B80-8C2D-43B9074A4E17Q34792091-DCC1283E-56A5-4915-A482-956FDBF1BF7AQ35065682-886AFF9C-BF15-455B-87F1-2AD5B658FA5EQ35078638-C1933F53-45BF-4353-90B9-78AC1E5130F3Q35220841-872F9959-F971-4683-8FB2-1CB67938FD1FQ35491160-2AB4C87B-F14B-410E-B363-EEB7C5FA205FQ35510313-7819C8F0-9919-479B-99CD-0B6D56247788Q35529695-E9CE1C3E-DE7C-4B0B-9DE3-501E28252EFCQ35551001-DC6427DA-88ED-47D4-A2B1-1EAC842F0638Q35603488-39C7A4FF-E854-4400-91A5-D20762EEAA3EQ35632000-20254F7D-CF8D-462E-B2CD-B13884A8DCE7Q35688796-FE5C2FAC-CA5C-405C-9526-B9566865301FQ36034871-41A5455D-5DE3-47AE-BF0B-0C4FA0A11905Q36161990-135E9DD8-474C-4C51-87AF-D42571DAAA2BQ36197290-446E0BEE-4E34-4DAA-B261-7E3723AE9EA6Q36326535-F2F9EC43-BF3E-4C17-96CE-D15E3E90AC18Q36355055-B0297A81-93CA-4A34-937E-7C799C30BA1FQ36553302-30120851-057F-4DDC-80A1-CD33C3416308Q36714253-3BE454FD-2510-4DAD-B979-315FAB631B23Q36786281-F4B4FFE5-F0FE-4B0D-B4C2-6AF86AE49A2BQ37071013-C2B1E13C-FC6D-4E92-90AF-A8E2E1EF8B91Q37312661-BAB084C1-E8EE-4D43-AA7D-228EFEB92BE5Q37323588-657C1BFF-DFE2-4D11-8340-CCA08C37E101Q37445587-C31E9D36-32F0-4BA0-8D56-91535E379687Q37539279-15E63644-EEC6-44AA-819E-9917C96AC8AD
P2860
Neurotoxic in vivo models of Parkinson's disease recent advances.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neurotoxic in vivo models of Parkinson's disease recent advances.
@ast
Neurotoxic in vivo models of Parkinson's disease recent advances.
@en
type
label
Neurotoxic in vivo models of Parkinson's disease recent advances.
@ast
Neurotoxic in vivo models of Parkinson's disease recent advances.
@en
prefLabel
Neurotoxic in vivo models of Parkinson's disease recent advances.
@ast
Neurotoxic in vivo models of Parkinson's disease recent advances.
@en
P1476
Neurotoxic in vivo models of Parkinson's disease recent advances
@en
P2093
J Timothy Greenamyre
Jason R Cannon
P356
10.1016/S0079-6123(10)84002-6
P577
2010-01-01T00:00:00Z